Treating Early-Stage DLBCL on the FLYER: What Lesson for Radiation Therapy?

Treating Early-Stage DLBCL on the FLYER: What Lesson for Radiation Therapy?

Bibliographic Details
Main Authors:	Kelsey Sokol, Amanda McBride, Adam Finn Binder, Pierluigi Porcu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Oncology
Subjects:	DLBCL favorable early-stage lymphoma CHOP (R-CHOP) radiation
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.686223/full

Similar Items

R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma
by: Mishima Yuko, et al.
Published: (2012-09-01)

Prediction and prognostic potential of NR3C1 gene expression level in DLBCL patients
by: Changjian Yan, et al.
Published: (2023-12-01)

Monoclonal antibodies binding to different epitopes of CD20 differentially sensitize DLBCL to different classes of chemotherapy
by: Brian Lee, et al.
Published: (2023-08-01)

Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL
by: Guido Lancman, et al.
Published: (2018-01-01)

Prognosis and complete remission rate of diffuse large B‐cell lymphoma patients in standard R‐CHOP with reduction of vincristine: A retrospective study
by: Fatemeh Riasi, et al.
Published: (2023-12-01)

Biweekly CHOP therapy improves therapeutic effect in the non-GCB subtype of diffuse large B-cell lymphoma
by: Zhang Qingyuan, et al.
Published: (2007-12-01)

A randomized controlled trial to assess safety and efficacy between terminal chop, stop and chop, and direct chop
by: Aprajita Sinha, et al.
Published: (2023-01-01)

Excellent survival after R‐Hyper‐CVAD in hospitalized patients with high‐risk large B‐cell lymphoma: The Karolinska experience
by: Kristina Sonnevi, et al.
Published: (2021-11-01)

The Prognostic Impact of Comorbidities in Patients with De-Novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP Immunochemotherapy in Curative Intent
by: Florian Kocher, et al.
Published: (2020-04-01)

Evaluation of the Effects of R-CHOP Chemotherapy on Brain Glucose Metabolism in Patients with Diffuse Large B Cell Lymphoma: A Baseline, Interim, and End-of-Treatment PET/CT Study
by: Haiyan Zhu, et al.
Published: (2022-10-01)

A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma
by: Adrián Mosquera Orgueira, et al.
Published: (2023-04-01)

Follicular lymphoma: first - line selection criteria of treatment
by: E S Nesterova, et al.
Published: (2019-08-01)

Comparison of “Nagahara Phaco-Chop” and “Stop-And-Chop Phacoemulsification Techniques”
by: Devrim Toslak, et al.
Published: (2018-07-01)

Comparison of power-free-chop and phaco-chop techniques for moderate nuclei
by: Lin Yao, et al.
Published: (2020-05-01)

Two cases of spindle cell variant diffuse large B-cell lymphoma of the uterine cervix
by: Hiroko Murata, et al.
Published: (2020-08-01)

Comparison of press-and-chop and Nagahara phaco-chop phacoemulsification nucleotomy techniques
by: Mao Xu, et al.
Published: (2021-07-01)

Long‐term remission and survival in dogs with high‐grade, B cell lymphoma treated with chemotherapy with or without sequential low‐dose rate half‐body irradiation
by: Matthew P. Best, et al.
Published: (2023-11-01)

c‐MYC and p53 expression highlight starry‐sky pattern as a favourable prognostic feature in R‐CHOP‐treated diffuse large B‐cell lymphoma
by: Antonin Bouroumeau, et al.
Published: (2021-11-01)

Nine-year experience in the treatment of patients with diffuse large B-cell lymphosarcoma
by: Aminat Umaraskhabovna Magomedova, et al.
Published: (2011-07-01)

GM-CSF enhanced the effect of CHOP and R-CHOP on inhibiting diffuse large B-cell lymphoma progression via influencing the macrophage polarization
by: Yu Zhang, et al.
Published: (2021-03-01)

Challenges and perspectives of first-line therapy in patients with diffuse B-cell lymphoma: A review
by: Lali G. Babicheva, et al.
Published: (2023-08-01)

Application of the capsulorhexis forceps assisted pre-chop performed in cataract surgery
by: Wen-Hai Wang, et al.
Published: (2017-09-01)

Resultados facodinámicos del chopping inverso en la cirugía de catarata 2009 Phacodynamic outcomes of the reversed chopping technique in the cataract surgery in 2009
by: Abel Plasencia Blanco, et al.
Published: (2011-12-01)

Resultados de la técnica stop and chop en la facoemulsificación Results of stop and chop technique in phacoemulsification
by: Juan Raúl Hernández Silva, et al.
Published: (2010-06-01)

Treatment of diffuse large b-cell lymphosarcoma with involvement of bone marrow in an old female patient
by: V I Zamiatina, et al.
Published: (2008-07-01)

A Comprehensive Review of Polatuzumab vedotin: Mechanisms, Clinical Applications, and Future Prospects
by: Divya Shanthi, et al.
Published: (2024-03-01)

Efficacy on chopping with lens loop-pad in the small incision extracapsular cataract surgery with intraocular lens implantation
by: Xiao-Ning Peng, et al.
Published: (2014-04-01)

The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B‐cell lymphoma
by: Steven Habbous, et al.
Published: (2020-10-01)

Outcomes of patients with double/triple expressor diffuse large B-cell lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single-center experience.
by: Kanta Devi, et al.
Published: (2021-01-01)

CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL
by: Antonin Bouroumeau, et al.
Published: (2021-11-01)

Peripheral T-cell lymphoma, not otherwise specified
by: Kunal Kishor Jha, et al.
Published: (2017-01-01)

Therapeutic Effect of CAOLD Chemotherapy Regimen on Patients With Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma: A Case Study
by: Yu Liu, et al.
Published: (2022-01-01)

Point and counterpoint: Polatuzumab vedotin in the front-line therapy for diffuse large B- cell lymphoma
by: Colin Thomas, et al.
Published: (2023-01-01)

Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study
by: Mariana Bastos-Oreiro, et al.
Published: (2024-03-01)

Controversies in the Front-Line Treatment of Systemic Peripheral T Cell Lymphomas
by: Marc Sorigue, et al.
Published: (2022-12-01)

TrkA is a binding partner of NPM‐ALK that promotes the survival of ALK+ T‐cell lymphoma
by: Wenyu Shi, et al.
Published: (2017-09-01)

Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi
by: Gloria Margiotta-Casaluci, et al.
Published: (2023-03-01)

EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
by: C. Martínez-Laperche, et al.
Published: (2022-09-01)

FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy
by: Beata Pyrzynska, et al.
Published: (2018-05-01)

Extrinsic apoptotic pathways: A new potential "Target" for more sufficient therapy in a case of cutaneous anaplastic large CD30+ ALK-T--cell lymphoma
by: Georgi Tchernev, et al.
Published: (2011-01-01)